Rafat Abonour, MD is professor of medicine, pathology, and laboratory medicine at Indiana University (IU) in Indianapolis, Indiana. Dr. Abonour is also director of the Multiple Myeloma and Waldenstrom Disease Program at IU Simon Cancer Center. He also serves as the Medical Director in the Clinical Research Office at the IU Simon Cancer Center. Dr. Abonour earned his medical degree from the University of Damascus in Syria. He completed his residency in internal medicine and fellowship in hematology at the University of Wisconsin in Madison, Wisconsin.

Dr. Abonour established and directs the multiple myeloma and plasma cell program at IU. His clinical interests include novel therapies for multiple myeloma and hematopoietic stem cell processing, including gene therapy. Dr Abonour is principal or co-investigator of several on-going clinical trials.

Dr. Abonour is a member of the Eastern Cooperative Group Data Monitoring Committee for Myeloma, the Scientific Research Committee at Indiana Cancer Center, and the Indiana University Executive Review Board. In addition, he is actively involved in a number of professional societies including the American Society of Hematology, where he is the Chair of the Scientific Committee on Plasma Cell Neoplasm (2015), and the International Society of Hematology. Dr. Abonour has authored or coauthored numerous peer-reviewed manuscripts, book chapters, and review articles. He has lectured nationally and internationally and received numerous awards, including the Trustee Teaching Award from Indiana University and the Excellence in Cancer Care Award from the Indianapolis Leukemia and Lymphoma Society. He also received the Sagamore of the Wabash award, the highest honor an Indiana governor can bestow, for his work on multiple myeloma on behalf of his patients.